Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.37 USD | -0.04% | +0.36% | +57.28% |
05-01 | North American Morning Briefing : Traders Wait for -2- | DJ |
04-30 | Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.28% | 2.09B | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- DCPH Stock
- News Deciphera Pharmaceuticals, Inc.
- Barclays Downgrades Deciphera Pharmaceuticals to Equal-Weight Rating From Overweight, Adjusts Price Target to $11 From $50